Insights

Gathering insights about Iridian…

Similar companies to Iridian

Iridian Tech Stack

Iridian uses 8 technology products and services including Facebook Pixel, Amazon Web Services, MySQL, and more. Explore Iridian's tech stack below.

Facebook Pixel
Analytics
Amazon Web Services
Cloud Hosting
MySQL
Database
jQuery
Javascript Libraries
Elementor
Page Builders
Yoast SEO
Search Engines
Google Tag Manager
Tag Management
Google Analytics
Web Analytics

Media & News

Viridian Therapeutics: The Song Remains The Same
Viridian Therapeutics is targeting thyroid eye disease with late-stage assets, and shares have dropped significantly over the past six months, despite no major negative news. Analyst sentiment remains bullish, with multiple Buy ratings and price targets far above current levels. The company has a couple of milestones upcoming in 2025 and more pivotal once scheduled in 2026 including a likely FDA approval.
Jun 09, 2025 | seekingalpha.com
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company's Board of Directors, made up entirely of independent directors, approved the grant of non-qualified stock options to purchase an aggregate of 23,400 shares of the company's common stock to one new employee (th.
Jun 05, 2025 | www.businesswire.com
Viridian Therapeutics to Participate in Upcoming June Investor Conferences
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that members of its management team will participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference (New York, NY): Presentation on Wednesday, June 4, at 7:35am ET Goldman Sachs 46th Annual Global Healthcare Conferenc.
May 30, 2025 | www.businesswire.com
Viridian Therapeutics Announces Positive Long-Term Durability Data from the Veligrotug Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease (TED)
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced positive long-term durability data from the THRIVE phase 3 clinical trial of veligrotug (“veli”), an intravenously delivered anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, in patients with active thyroid eye disease (TED). TED is an autoimmun.
May 20, 2025 | www.businesswire.com
Viridian Therapeutics Receives FDA Breakthrough Therapy Designation for Veligrotug for the Treatment of Thyroid Eye Disease (TED)
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the United States Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to veligrotug (“veli”), the company's lead anti-insulin-like growth factor-1 receptor (IGF-1R) drug candidate for the treatment of TED. Breakthrough Therapy D.
May 07, 2025 | www.businesswire.com
Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss, Lags Revenue Estimates
Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $0.95. This compares to loss of $0.79 per share a year ago.
May 06, 2025 | www.zacks.com
Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2025 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today reported recent business highlights and financial results for the first quarter ended March 31, 2025. “We continue to execute across the portfolio as we work towards submitting the veligrotug BLA in the second half of 2025, advancing our VRDN-003 subcutaneous clinical tri.
May 06, 2025 | www.businesswire.com

Iridian's Email Address Formats

Iridian uses at least 2 format(s):

Iridian Email Formats	Example	Percentage
First@iridian.co	John@iridian.co	100%

Frequently Asked Questions

Where is Iridian's headquarters located?

Iridian's main headquarters is located at 99 Carrera 11, Bogotá, Colombia 252211, CO. The company has employees across 4 continents, including South AmericaNorth AmericaEurope.

What is Iridian's stock symbol?

Iridian is a publicly traded company; the company's stock symbol is VRDN.

What is Iridian's official website and social media links?

Iridian's official website is iridian.io and has social profiles on LinkedIn.

How much revenue does Iridian generate?

As of June 2025, Iridian's annual revenue reached $15M.

What is Iridian's NAICS code?

Iridian's NAICS code is 5112 - Software Publishers.

How many employees does Iridian have currently?

As of June 2025, Iridian has approximately 51 employees across 4 continents, including South AmericaNorth AmericaEurope. Key team members include Chief Executive Officer: S. W.Chief Technology Officer: M. C.Ceo: F. C.. Explore Iridian's employee directory with LeadIQ.

What industry does Iridian belong to?

Iridian operates in the Software Development industry.

What technology does Iridian use?

Iridian's tech stack includes Facebook PixelAmazon Web ServicesMySQLjQueryElementorYoast SEOGoogle Tag ManagerGoogle Analytics.

What is Iridian's email format?

Iridian's email format typically follows the pattern of . Find more Iridian email formats with LeadIQ.

When was Iridian founded?

Iridian was founded in 2011.

Iridian

Software DevelopmentColombia51-200 Employees

Iridian is a digital technology company that, through the development and integration of technologies, makes processes, services, or channels in any area of your company more efficient.